LABCORP HOLDINGS INC. — Director's Dealing 2020

Nov 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-11-02

Reporting Person: EISENBERG GLENN A (Chief Financial Officer, EVP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-02	Common Stock	M	9024	—	Acquired	35148	Direct
2020-11-02	Common Stock	F	4034	$207.23	Disposed	31114	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-02	Restricted Stock Unit	$	M	9024	Disposed		Common Stock (9024)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units will vest on November 1, 2021; and 40% of the Restricted Stock Units will vest on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that may adjust the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.